Nasdaq:US$36.56 (-0.93) | HKEX:HK$58.70 (+0.05) | AIM:£5.38 (-0.09)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 4 Jul 2006

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate

1 items
a060704